Impact of COVID-19 Lockdown on the Metabolic Control Parameters in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis
- PMID: 35255551
- PMCID: PMC8987692
- DOI: 10.4093/dmj.2021.0125
Impact of COVID-19 Lockdown on the Metabolic Control Parameters in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis
Abstract
Background: Abrupt implementation of lockdowns during the coronavirus disease 2019 (COVID-19) pandemic affected the management of diabetes mellitus in patients worldwide. Limited access to health facilities and lifestyle changes potentially affected metabolic parameters in patients at risk. We conducted a meta-analysis to determine any differences in the control of metabolic parameters in patients with diabetes, before and during lockdown.
Methods: We performed searches of five databases. Meta-analyses were carried out using random- or fixed-effect approaches to glycaemic control parameters as the primary outcome: glycosylated hemoglobin (HbA1c), random blood glucose (RBG), fasting blood glucose (FBG), time-in-range (TIR), time-above-range (TAR), time-below-range (TBR). Mean difference (MD), confidence interval (CI), and P value were calculated. Lipid profile was a secondary outcome and is presented as a descriptive analysis.
Results: Twenty-one studies enrolling a total of 3,992 patients with type 1 or type 2 diabetes mellitus (T1DM or T2DM) were included in the study. Patients with T1DM showed a significant improvement of TIR and TAR (MD=3.52% [95% CI, 0.29 to 6.74], I2=76%, P=0.03; MD=-3.36% [95% CI, -6.48 to -0.25], I2=75%, P=0.03), while FBG among patients with T2DM significantly worsened (MD=3.47 mg/dL [95% CI, 1.22 to 5.73], I2=0%, P<0.01). No significant difference was found in HbA1c, RBG, and TBR. Use of continuous glucose monitoring in T1DM facilitated good glycaemic control. Significant deterioration of lipid parameters during lockdown, particularly triglyceride, was observed.
Conclusion: Implementation of lockdowns during the COVID-19 pandemic did not worsen glycaemic control in patients with diabetes. Other metabolic parameters improved during lockdown, though lipid parameters, particularly triglyceride, worsened.
Keywords: COVID-19; Diabetes mellitus; Meta-analysis; Systematic review; Triglycerides.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures




Similar articles
-
The impact of COVID lockdown on glycaemic control in paediatric patients with type 1 diabetes: A systematic review and meta-analysis of 22 observational studies.Front Endocrinol (Lausanne). 2022 Nov 30;13:1069559. doi: 10.3389/fendo.2022.1069559. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36531473 Free PMC article.
-
Glycaemic control during the lockdown for COVID-19 in adults with type 1 diabetes: A meta-analysis of observational studies.Diabetes Res Clin Pract. 2021 Oct;180:109066. doi: 10.1016/j.diabres.2021.109066. Epub 2021 Sep 23. Diabetes Res Clin Pract. 2021. PMID: 34563586 Free PMC article. Review.
-
Socioeconomic status and the effect of prolonged pandemic confinement on anthropometric and glycaemic outcomes in adults with type 2 diabetes mellitus.Prim Care Diabetes. 2024 Jun;18(3):308-318. doi: 10.1016/j.pcd.2024.02.002. Epub 2024 Mar 6. Prim Care Diabetes. 2024. PMID: 38448261
-
COVID-19 Lockdown Periods in 2020: Good Maintenance of Metabolic Control in Adults with Type 1 and Type 2 Diabetes.Exp Clin Endocrinol Diabetes. 2022 Sep;130(9):621-626. doi: 10.1055/a-1743-2537. Epub 2022 Feb 18. Exp Clin Endocrinol Diabetes. 2022. PMID: 35181878
-
The impact of the COVID-19 pandemic on glycaemic control in people with diabetes: A systematic review and meta-analysis.Diabetes Obes Metab. 2022 Sep;24(9):1850-1860. doi: 10.1111/dom.14771. Epub 2022 Jun 20. Diabetes Obes Metab. 2022. PMID: 35603919 Free PMC article.
Cited by
-
Telemedicine Decreases No-Show Rates and Achieves Comparable Outcomes in Publicly Insured Patients With Type 2 Diabetes.J Diabetes Sci Technol. 2025 Jul 29:19322968251362115. doi: 10.1177/19322968251362115. Online ahead of print. J Diabetes Sci Technol. 2025. PMID: 40727953 Free PMC article.
-
Disruption of diabetes and hypertension care during the COVID-19 pandemic and recovery approaches in the Latin America and Caribbean region: a scoping review protocol.BMJ Open. 2024 Jan 22;14(1):e074443. doi: 10.1136/bmjopen-2023-074443. BMJ Open. 2024. PMID: 38262656 Free PMC article.
-
Effect of the SARS-CoV-2 pandemic on metabolic control in patients with type 2 diabetes: a 5-year cohort follow-up managed by a dynamic multidisciplinary team in Northeastern Mexico.Diabetol Metab Syndr. 2024 Apr 25;16(1):94. doi: 10.1186/s13098-024-01318-8. Diabetol Metab Syndr. 2024. PMID: 38664823 Free PMC article.
-
Retrospective Study on the Impact of COVID-19 Lockdown on Patients with Type 2 Diabetes in Northern Taiwan.Diabetes Metab Syndr Obes. 2023 Aug 24;16:2539-2547. doi: 10.2147/DMSO.S422617. eCollection 2023. Diabetes Metab Syndr Obes. 2023. PMID: 37645235 Free PMC article.
-
Changes in body weight and glycemic control in association with COVID-19 Shutdown among 23,000 adults with type 2 diabetes.Acta Diabetol. 2023 Jun;60(6):787-795. doi: 10.1007/s00592-023-02056-5. Epub 2023 Mar 9. Acta Diabetol. 2023. PMID: 36894712 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical